HIBRUKA (Orelabrutinib)

Approval for HIBRUKA (Orelabrutinib) in Singapore in MZL

Approval of HIBRUKA (Orelabrutinib) for the Treatment of R/R MZL in Singapore

Format

JPEG

Source

InnoCare Pharma

Téléchargements